Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prospective registry of adult patients receiving therapeutic plasma exchange with a presumptive diagnosis of thrombotic microangiopathy (TMA): The Turkish hematology research and education group (ThREG)-TMA02 study.
Akpınar S, Tekgunduz E, Erkurt MA, Esen R, Yılmaz M, Karakus V, Vural F, Gediz F, Aydogdu I, Kaynar L, Korkmaz S, Goker H, Kelkitli E, Ayyıldız O, Demirkan F. Akpınar S, et al. Among authors: goker h. Transfus Apher Sci. 2021 Nov 16:103312. doi: 10.1016/j.transci.2021.103312. Online ahead of print. Transfus Apher Sci. 2021. PMID: 34799244
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group.
Beksac M, Haznedar R, Firatli-Tuglular T, Ozdogu H, Aydogdu I, Konuk N, Sucak G, Kaygusuz I, Karakus S, Kaya E, Ali R, Gulbas Z, Ozet G, Goker H, Undar L. Beksac M, et al. Among authors: goker h. Eur J Haematol. 2011 Jan;86(1):16-22. doi: 10.1111/j.1600-0609.2010.01524.x. Epub 2010 Nov 22. Eur J Haematol. 2011. PMID: 20942865 Clinical Trial.
EUTOS CML prognostic scoring system predicts ELN-based 'event-free survival' better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate.
Uz B, Buyukasik Y, Atay H, Kelkitli E, Turgut M, Bektas O, Eliacik E, Isik A, Aksu S, Goker H, Sayinalp N, Ozcebe OI, Haznedaroglu IC. Uz B, et al. Among authors: goker h. Hematology. 2013 Sep;18(5):247-52. doi: 10.1179/1607845412Y.0000000071. Epub 2013 Mar 20. Hematology. 2013. PMID: 23540886 Free article.
Hyper-CVAD regimen in routine management of adult acute lymphoblastic leukemia: a retrospective multicenter study.
Buyukasik Y, Acar K, Kelkitli E, Uz B, Serefhanoglu S, Ozdemir E, Pamukcuoglu M, Atay H, Bektas O, Sucak GT, Turgut M, Aksu S, Yagci M, Sayınalp N, Ozcebe OI, Goker H, Haznedaroglu IC. Buyukasik Y, et al. Among authors: goker h. Acta Haematol. 2013;130(3):199-205. doi: 10.1159/000351172. Epub 2013 Jun 19. Acta Haematol. 2013. PMID: 23797290 Clinical Trial.
Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: a single center experience.
Goker H, Ozdemir E, Uz B, Buyukasik Y, Turgut M, Serefhanoglu S, Aksu S, Sayinalp N, Haznedaroglu IC, Tekin F, Karacan Y, Unal S, Eliacik E, Isik A, Ozcebe OI. Goker H, et al. Transfus Apher Sci. 2013 Dec;49(3):590-9. doi: 10.1016/j.transci.2013.07.030. Epub 2013 Aug 8. Transfus Apher Sci. 2013. PMID: 23981652
Retrospective analysis of adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic cell transplantation: A multicenter experience of daily practice.
Tekgündüz E, Kaynar L, Göker H, Kaya AH, Turak EE, Eliaçık E, Kayıkçı Ö, Çetin M, Büyükaşık Y, Eser B, Altuntaş F. Tekgündüz E, et al. Among authors: goker h. Transfus Apher Sci. 2016 Feb;54(1):41-7. doi: 10.1016/j.transci.2016.01.010. Epub 2016 Jan 11. Transfus Apher Sci. 2016. PMID: 26810140
Hematopoietic cell transplantation activity of Turkey in 2014: Ongoing increase in HCT rates.
Tekgündüz E, Şencan İ, Kapuağası A, Ünal D, Öztürk M, Gümüş E, Göker H, Tavil EB, Ertem M, Çetin M, Arat M, Soysal T, Karakaşlı O, Sur HY, Yeşilipek A, Ferhanoğlu B, Uçkan D, İlhan O, Altuntaş F. Tekgündüz E, et al. Among authors: goker h. Transfus Apher Sci. 2016 Feb;54(1):53-9. doi: 10.1016/j.transci.2016.01.013. Epub 2016 Jan 11. Transfus Apher Sci. 2016. PMID: 26899916
Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Daily Practice: A Multicenter Experience.
Tekgündüz E, Göker H, Kaynar L, Sarı İ, Pala Ç, Doğu MH, Öztürk E, Turgut B, Korkmaz S, Tetik A, Büyükaşık Y, Hacıoğlu SK, Bozdağ SC, Özdemir E, Altuntaş F. Tekgündüz E, et al. Among authors: goker h. Clin Lymphoma Myeloma Leuk. 2016 May;16(5):269-74. doi: 10.1016/j.clml.2016.01.007. Epub 2016 Feb 4. Clin Lymphoma Myeloma Leuk. 2016. PMID: 26927932
Current practice of autologous hematopoietic progenitor cell mobilization in adult patients with multiple myeloma and lymphoma: The results of a survey from Turkish hematology research and education group (ThREG).
Tekgündüz E, Demirkan F, Vural F, Göker H, Özdoğu H, Kiki İ, Aydoğdu İ, Kaynar L, Erkurt MA, Çağırgan S, Beşışık S, Dağdaş S, Koca E, Kadıköylü G, Gündüz E, Yılmaz M, Beköz H, Ural AU, Baştürk A, Arat M, Albayrak M, Öztürk E, Akyol A, Bolaman AZ, Nevruz O, Özkan HA, Özgür G, Altuntaş F. Tekgündüz E, et al. Among authors: goker h. Transfus Apher Sci. 2017 Dec;56(6):804-808. doi: 10.1016/j.transci.2017.11.010. Epub 2017 Nov 9. Transfus Apher Sci. 2017. PMID: 29153305
Autologous hematopoietic progenitor cell mobilization and collection in adult patients presenting with multiple myeloma and lymphoma: A position-statement from the Turkish Society of Apheresis (TSA).
Tekgündüz E, Arat M, Göker H, Özdoğu H, Kaynar L, Çağırgan S, Erkurt MA, Vural F, Kiki İ, Altuntaş F, Demirkan F; Turkish Society of Apheresis (TSA). Tekgündüz E, et al. Among authors: goker h. Transfus Apher Sci. 2017 Dec;56(6):845-849. doi: 10.1016/j.transci.2017.11.025. Epub 2017 Nov 10. Transfus Apher Sci. 2017. PMID: 29153306
222 results